Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Grassmann, Felix ^a   Fleckenstein, Monika ^b   Chew, Emily Y ^c   Strunz, Tobias ^a   Schmitz Valckenberg, Steffen ^b   Göbel, Arno P ^b   Klein, Michael L ^d   Ratnapriya, Rinki ^c   Swaroop, Anand ^c   Holz, Frank G ^b   Weber, Bernhard H F ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c NATIONAL EYE INSTITUTE   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; AUTOFLUORESCENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; GENETIC RISK; GENOTYPE; GEOGRAPHIC ATROPHY; HEREDITY; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; ALLELE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; VERY ELDERLY;

ARMS2 PROTEIN, HUMAN; PROTEIN;

AGED; AGED, 80 AND OVER; ALLELES; DISEASE PROGRESSION; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GEOGRAPHIC ATROPHY; HUMANS; PROTEINS;

EID: 84930642724     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126636     Document Type: Article

References (41)

1. Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, et al. (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Heal 2: e106-16. doi: 10.1016/S2214-109X(13)70145-1 PMID: 25104651
2. Sallo FB, Peto T, Leung I, Xing W, Bunce C, Bird AC (2009) The International Classification system and the progression of age-related macular degeneration. Curr Eye Res 34: 238-240. doi: 10.1080/02713680802714058 PMID: 19274532
3. Kinnunen K, Petrovski G, Moe MC, Berta A, Kaarniranta K (2012) Molecular mechanisms of retinal pigment epithelium damage and development of age-related macular degeneration. Acta Ophthalmol 90: 299-309. doi: 10.1111/j.1755-3768.2011.02179.x PMID: 22112056
4. Abdelsalam A, Del Priore L, Zarbin MA (n.d.) Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol 44: 1-29. PMID: 10466585
5. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY (2012) Age-related macular degeneration. Lancet 379: 1728-1738. doi: 10.1016/S0140-6736(12)60282-7 PMID: 22559899
6. Schmidt-Erfurth U, Chong V, Loewenstein A, Larsen M, Souied E, Schlingemann R, et al. (2014) Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol 98: 1144-1167. doi: 10.1136/bjophthalmol-2014-305702 PMID: 25136079
7. Augood C a, Vingerling JR, de Jong PTVM, Chakravarthy U, Seland J, Soubrane G, et al. (2006) Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 124: 529-535. PMID: 16606879
8. Klein R, Klein BEK, Knudtson MD, Meuer SM, Swift M, Gangnon RE (2007) Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 114: 253-262. PMID: 17270675
9. Lindblad AS, Lloyd PC, Clemons TE, Gensler GR, Ferris FL, Klein ML, et al. (2009) Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. Arch Ophthalmol 127: 1168-1174. doi: 10.1001/archophthalmol.2009.198 PMID: 19752426
10. Klein ML, Ferris FL, Francis PJ, Lindblad AS, Chew EY, Hamon SC, et al. (2010) Progression of geographic atrophy and genotype in age-related macular degeneration. Ophthalmology 117: 1554-9, 1559.e1. doi: 10.1016/j.ophtha.2009.12.012 PMID: 20381870
11. Fleckenstein M, Adrion C, Schmitz-Valckenberg S, Göbel AP, Bindewald-Wittich A, Scholl HPN, et al. (2010) Concordance of disease progression in bilateral geographic atrophy due to AMD. Invest Ophthalmol Vis Sci 51: 637-642. doi: 10.1167/iovs.09-3547 PMID: 19797219
12. Fleckenstein M, Schmitz-Valckenberg S, Adrion C, Visvalingam S, Göbel AP, Mössner A, et al. (2011) Progression of age-related geographic atrophy: role of the fellow eye. Invest Ophthalmol Vis Sci 52: 6552-6557. doi: 10.1167/iovs.11-7298 PMID: 21757586
13. Sunness JS, Gonzalez-Baron J, Applegate CA, Bressler NM, Tian Y, Hawkins B, et al. (1999) Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Ophthalmology 106: 1768-1779. PMID: 10485549
14. Fritsche LG, Chen W, Schu M, Yaspan BL, Yu Y, Thorleifsson G, et al. (2013) Seven new loci associated with age-related macular degeneration. Nat Genet 45: 433-9, 439e1-2. doi: 10.1038/ng.2578 PMID: 23455636
15. Fritsche LG, Fariss RN, Stambolian D, Abecasis GR, Curcio CA, Swaroop A (2014) Age-related macular degeneration: genetics and biology coming together. Annu Rev Genomics Hum Genet 15: 151-171. doi: 10.1146/annurev-genom-090413-025610 PMID: 24773320
16. Scholl HPN, Fleckenstein M, Fritsche LG, Schmitz-Valckenberg S, Göbel A, Adrion C, et al. (2009) CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. PLoS One 4: e7418. doi: 10.1371/journal.pone.0007418 PMID: 19823576
17. Caire J, Recalde S, Velazquez-Villoria A, Garcia-Garcia L, Reiter N, Anter J, et al. (2014) Growth of Geographic Atrophy on Fundus Autofluorescence and Polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in Age-Related Macular Degeneration. JAMA Ophthalmol.
18. Feuer WJ, Yehoshua Z, Gregori G, Penha FM, Chew EY, Ferris FL, et al. (2013) Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of age-related eye disease study report no. 26. JAMA Ophthalmol 131: 110-111. doi: 10.1001/jamaophthalmol.2013.572 PMID: 23307222
19. Dreyhaupt J, Mansmann U, Pritsch M, Dolar-Szczasny J, Bindewald A, Holz FG (2005) Modelling the natural history of geographic atrophy in patients with age-related macular degeneration. Ophthalmic Epidemiol 12: 353-362. PMID: 16283987
20. Holz FG, Bindewald-Wittich A, Fleckenstein M, Dreyhaupt J, Scholl HPN, Schmitz-Valckenberg S (2007) Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol 143: 463-472. PMID: 17239336
21. Grassmann F, Fritsche LG, Keilhauer CN, Heid IM, Weber BHF (2012) Modelling the genetic risk in age-related macular degeneration. PLoS One 7: e37979. doi: 10.1371/journal.pone.0037979 PMID: 22666427
22. Wickham H (2009) ggplot2: Elegant Graphics for Data Analysis. Springer New York.
23. R Development Core Team (2010) R: A Language and Environment for Statistical Computing.
24. Viechtbauer W (2010) Conducting Meta-Analyses in R with the metafor Package. J Stat Softw 36: 1-48.
25. Klein R, Meuer SM, Knudtson MD, Klein BEK (2008) The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study. Am J Ophthalmol 146: 692-699. doi: 10.1016/j.ajo.2008.05.050 PMID: 18672224
26. Sunness JS, Margalit E, Srikumaran D, Applegate CA, Tian Y, Perry D, et al. (2007) The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. Ophthalmology 114: 271-277. PMID: 17270676
27. Seddon JM, Reynolds R, Yu Y, Rosner B (2014) Three new genetic loci (R1210C in CFH, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration. PLoS One 9: e87047. doi: 10.1371/journal.pone.0087047 PMID: 24498017
28. Klein ML, Francis PJ, Ferris FL, Hamon SC, Clemons TE (2011) Risk Assessment Model for Development of Advanced Age-Related Macular Degeneration. Arch Ophthalmol 129: 1543-1550. doi: 10.1001/archophthalmol.2011.216 PMID: 21825180
29. Fritsche LG, Fleckenstein M, Fiebig BS, Schmitz-Valckenberg S, Bindewald-Wittich A, Keilhauer CN, et al. (2012) A subgroup of age-related macular degeneration is associated with mono-allelic sequence variants in the ABCA4 gene. Invest Ophthalmol Vis Sci 53: 2112-2118. doi: 10.1167/iovs.11-8785 PMID: 22427542
30. Smailhodzic D, Fleckenstein M, Theelen T, Boon CJF, van Huet RAC, van de Ven JPH, et al. (2011) Central areolar choroidal dystrophy (CACD) and age-related macular degeneration (AMD): differentiating characteristics in multimodal imaging. Invest Ophthalmol Vis Sci 52: 8908-8918. doi: 10.1167/iovs.11-7926 PMID: 22003107
31. Fritsche LG, Loenhardt T, Janssen A, Fisher S a, Rivera A, Keilhauer CN, et al. (2008) Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet 40: 892-896. doi: 10.1038/ng.170 PMID: 18511946
32. Friedrich U, Myers C a., Fritsche LG, Milenkovich A, Wolf A, Corbo JC, et al. (2011) Risk- and non-risk-associated variants at the 10q26 AMD locus influence ARMS2 mRNA expression but exclude pathogenic effects due to protein deficiency. Hum Mol Genet 20: 1387-1399. doi: 10.1093/hmg/ddr020 PMID: 21252205
33. Heurich M, Martínez-Barricarte R, Francis NJ, Roberts DL, Rodríguez de Córdoba S, Morgan BP, et al. (2011) Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk. Proc Natl Acad Sci U S A 108: 8761-8766. doi: 10.1073/pnas.1019338108 PMID: 21555552
34. Ramaglia V, Hughes TR, Donev RM, Ruseva MM, Wu X, Huitinga I, et al. (2012) C3-dependent mechanism of microglial priming relevant to multiple sclerosis. Proc Natl Acad Sci U S A 109: 965-970. doi: 10.1073/pnas.1111924109 PMID: 22219359
35. Griffiths MR, Neal JW, Fontaine M, Das T, Gasque P (2009) Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis. J Immunol 182: 4368-4377. doi: 10.4049/jimmunol.0800205 PMID: 19299737
36. Rahpeymai Y, Hietala MA, Wilhelmsson U, Fotheringham A, Davies I, Nilsson A-K, et al. (2006) Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J 25: 1364-1374. PMID: 16498410
37. Van Beek J, Nicole O, Ali C, Ischenko A, MacKenzie ET, Buisson A, et al. (2001) Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death. Neuroreport 12: 289-293. PMID: 11209937
38. Steiner T, Francescut L, Byrne S, Hughes T, Jayanthi A, Guschina I, et al. (2014) Protective role for properdin in progression of experimental murine atherosclerosis. PLoS One 9: e92404. doi: 10.1371/journal.pone.0092404 PMID: 24667818
39. Steiner B, Wolf S, Kempermann G (2006) Adult neurogenesis and neurodegenerative disease. Regen Med 1: 15-28. PMID: 17465817
40. Pekny M, Wilhelmsson U, Bogestål YR, Pekna M (2007) The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 82: 95-111. PMID: 17678957
41. Klein ML, Francis PJ, Rosner B, Reynolds R, Hamon SC, Schultz DW, et al. (2008) CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology 115: 1019-1025. doi: 10.1016/j.ophtha.2008.01.036 PMID: 18423869